Top

Published in:

01-12-2013 | Review Article

Designing Liver Resections and Pushing the Envelope with Resections for Hepatic Colorectal Metastases

Authors: Mary L. Guye, Hans F. Schoellhammer, Louisa W. Chiu, Joseph Kim, Lily L. Lai, Gagandeep Singh

Published in: Indian Journal of Surgical Oncology | Issue 4/2013

Abstract

Current concepts in the management of hepatic metastases have changed dramatically over the past two decades. Multidisciplinary therapies including chemotherapy, surgery, and regional therapy have alone and in combination significantly improved the survival of patients with metastatic colorectal cancer. Conditions that were previously considered hopeless and treated merely for palliation can now be approached with curative intent. In this paper, we review the surgical treatment for colorectal cancer liver metastasis (CRLM) and describe a paradigm-shift in the management of complex heretofore-considered unresectable CRLM. Utilizing advanced multidisciplinary treatment strategies has improved the prognosis of patients with stage IV colorectal cancer to the point where we may question whether CRLM are now a chronic disease.

Siegel R et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–41PubMedCrossRef

Donadon M et al (2007) New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res 1(1):20–7PubMedCentralPubMed

Abdalla EK et al (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1271–80PubMedCrossRef

Baden H, Andersen B (1975) Survival of patients with untreated liver metastases from colorectal cancer. Scand J Gastroenterol 10(2):221–3PubMed

Bengtsson G et al (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141(5):586–9PubMedCrossRef

Gallagher DJ, Kemeny N (2010) Metastatic colorectal cancer: from improved survival to potential cure. Oncology 78(3–4):237–48PubMedCrossRef

Charnsangavej C et al (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1261–8PubMedCrossRef

Abdalla EK et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239(6):818–25, discussion 825–7PubMedCrossRef

Choti MA et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235(6):759–66PubMedCrossRef

10.

Fong Y et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15(3):938–46PubMed

11.

Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J, Fürst G, Topp SA. (2012) In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg 100(3):388–94

12.

Narita M et al (2012) What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy? Ann Surg Oncol 19(8):2526–38PubMedCrossRef

13.

Scoggins CR et al (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16(1):35–41PubMedCrossRef

14.

Zorzi D et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94(3):274–86PubMedCrossRef

15.

Bipat S et al (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis–meta-analysis. Radiology 237(1):123–31PubMedCrossRef

16.

Fong Y et al (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178(4):282–7PubMedCrossRef

17.

Wiering B, Ruers TJ, Oyen WJ (2004) Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Expert Rev Anticancer Ther 4(4):607–13PubMedCrossRef

18.

Wiering B et al (2008) Controversies in the management of colorectal liver metastases: role of PET and PET/CT. Dig Surg 25(6):413–20PubMedCrossRef

19.

Ekberg H et al (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73(9):727–31PubMedCrossRef

20.

Pawlik TM, Schulick RD, Choti MA (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13(1):51–64PubMedCrossRef

21.

Yoo PS et al (2006) Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. Clin Colorectal Cancer 6(3):202–7PubMedCrossRef

22.

Chua TC, Morris DL (2012) Resectable colorectal liver metastases: optimal sequencing of chemotherapy. J Gastrointest Cancer 43(3):496–8PubMedCrossRef

23.

Egger ME, Cannon RM, Metzger TL, Nowacki M, Kelly L, Tatum C, Scoggins CR, Callender GG, McMasters KM, Martin RC 2nd (2013) Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg 216(4):845–56

24.

Karoui M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243(1):1–7PubMedCrossRef

25.

Nanji S et al (2013) Up-front Hepatic Resection for Metastatic Colorectal Cancer Results in Favorable Long-term Survival. Ann Surg Oncol 20(1):295–304PubMedCrossRef

26.

Parks R et al (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204(5):753–61, discussion 761–3PubMedCrossRef

27.

Nordlinger B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007–16PubMedCentralPubMedCrossRef

28.

Adam R et al (2007) Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 16(3):525–36, viiiPubMedCrossRef

29.

Adam R et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240(4):644–57, discussion 657–8PubMed

30.

Adam R et al (2000) Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 232(6):777–85PubMedCrossRef

31.

Wicherts DA et al (2008) Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 248(6):994–1005PubMedCrossRef

32.

Adam R et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8(4):347–53PubMedCrossRef

33.

Benoist S, Nordlinger B (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16(9):2385–90PubMedCrossRef

34.

Nordlinger B, Benoist S (2006) Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol 24(31):4954–5PubMedCrossRef

35.

Reddy SK et al (2012) Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases? J Surg Oncol 105(1):55–9PubMedCrossRef

36.

Venook AP (2003) Induction therapy in patients with metastatic colorectal cancer. Semin Oncol 30(4 Suppl 12):25–9PubMedCrossRef

37.

Covey AM et al (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247(3):451–5PubMedCrossRef

38.

Abulkhir A et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57PubMedCrossRef

39.

Jaeck D et al (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240(6):1037–49, discussion 1049–51PubMedCrossRef

40.

Vauthey JN, Zorzi D, Pawlik TM (2005) Making unresectable hepatic colorectal metastases resectable–does it work? Semin Oncol 32(6 Suppl 9):S118–22PubMedCrossRef

41.

Lalmahomed ZS et al (2011) Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? World J Surg 35(3):656–61PubMedCentralPubMedCrossRef

42.

Kingham TP et al (2012) Patterns of recurrence after ablation of colorectal cancer liver metastases. Ann Surg Oncol 19(3):834–41PubMedCrossRef

43.

Nathan H et al (2010) Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg 210(5):755–64, 764–6PubMedCrossRef

44.

Inoue Y et al (2012) Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer. J Gastrointest Surg 16(6):1171–80PubMedCrossRef

45.

Ayez N et al (2012) Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann Surg Oncol 19(5):1618–27PubMedCentralPubMedCrossRef

46.

Dhir M et al (2011) Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg 254(2):234–42PubMedCrossRef

47.

Nuzzo G et al (2008) Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 143(3):384–93PubMedCrossRef

48.

Zorzi D et al (2006) Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10(1):86–94PubMedCrossRef

49.

Pawlik TM et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241(5):715–22, discussion 722–4PubMedCrossRef

50.

Rees M, Plant G, Bygrave S (1997) Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84(8):1136–40PubMedCrossRef

51.

Stang A et al (2009) A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 45(10):1748–56PubMedCrossRef

52.

Bale R et al (2012) Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol 22(4):930–7PubMedCrossRef

53.

Lee KH et al (2012) Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer. Korean J Gastroenterol 59(3):218–23PubMedCrossRef

54.

Kulaylat MN, Gibbs JF (2010) Thermoablation of colorectal liver metastasis. J Surg Oncol 101(8):699–705PubMedCrossRef

55.

Wu YZ et al (2011) Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol 17(36):4143–8PubMedCrossRef

56.

Lorentzen T, Skjoldbye BO, Nolsoe CP (2011) Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall Med 32(5):492–6PubMedCrossRef

57.

Ito K et al (2010) Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J 16(2):103–10PubMedCrossRef

58.

Giulianotti PC et al (2010) Minimally invasive sequential treatment of synchronous colorectal liver metastases by laparoscopic colectomy and robotic right hepatectomy. Int J Colorectal Dis 25(12):1507–11PubMedCrossRef

59.

Chua TC et al (2012) Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases–a systematic review. Eur J Cancer 48(12):1757–65PubMedCrossRef

60.

Elias D et al (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90(5):567–74PubMedCrossRef

61.

Elias D et al (2004) Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 11(3):274–80PubMedCrossRef

62.

Pulitano C et al (2011) Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 18(5):1380–8PubMedCrossRef

63.

Chua TC et al (2012) Viewing metastatic colorectal cancer as a curable chronic disease. Am J Clin Oncol 35(1):77–80PubMedCrossRef

64.

Elias D et al (1998) Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 24(3):174–9PubMedCrossRef

65.

Chua TC et al (2011) Predictors of cure after hepatic resection of colorectal liver metastases: an analysis of actual 5- and 10-year survivors. J Surg Oncol 103(8):796–800PubMedCrossRef

66.

Pulitano C et al (2010) What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 12(4):244–9

67.

Tomlinson JS et al (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25(29):4575–80PubMedCrossRef

68.

Ambiru S et al (1998) Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 82(2):274–8PubMedCrossRef

69.

Gonzalez M et al (2012) Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases. World J Surg 36(2):386–91PubMedCrossRef

70.

Inoue M et al (2000) Surgery for pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 70(2):380–3PubMedCrossRef

71.

Regnard JF et al (1998) Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 66(1):214–8, discussion 218–9PubMedCrossRef

Title: Designing Liver Resections and Pushing the Envelope with Resections for Hepatic Colorectal Metastases
Authors: Mary L. Guye
Hans F. Schoellhammer
Louisa W. Chiu
Joseph Kim
Lily L. Lai
Gagandeep Singh
Publication date: 01-12-2013
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 4/2013
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-013-0256-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Designing Liver Resections and Pushing the Envelope with Resections for Hepatic Colorectal Metastases

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2013

Lararoscopic Retroperitoneal Lymph Node Dissection for Paratesticular Rhabdomyosarcoma in Older Children/Adolescents

Role of Imprint/Exfoliative Cytology in Ulcerated Skin Neoplasms

Prolapsed Anorectal Melanoma

Burned Out Seminomatous Testicular Tumor with Retroperitoneal Lymph Node Metastasis: A Case Report

A Case of Giant Advanced Sebaceous Gland Carcinoma

Low Grade Malignant Proliferating Pilar Tumor Arising from Breast Skin Simulating Squamous Cell Carcinoma, a Case Report